Clinical Efficacy of Modified Qilang Prescription in Treatment of Drug-dependent Constipation with Qi and Yin Deficiency and Its Effect on MTL， VIP， 5-HT， and 5-HT4R in Peripheral Blood

Zhe SHI; Meng-en ZHOU; Ke-hui ZHANG; Meng-xing CAO; Yong LI

doi:10.13422/j.cnki.syfjx.20211593

您当前的位置：

首页 >

文章列表页 >

Clinical Efficacy of Modified Qilang Prescription in Treatment of Drug-dependent Constipation with Qi and Yin Deficiency and Its Effect on MTL， VIP， 5-HT， and 5-HT4R in Peripheral Blood

Clinic | 更新时间：2021-07-15

- Clinical Efficacy of Modified Qilang Prescription in Treatment of Drug-dependent Constipation with Qi and Yin Deficiency and Its Effect on MTL， VIP， 5-HT， and 5-HT4R in Peripheral Blood
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 15, Pages: 51-56(2021)
- 作者机构：
  
  上海中医药大学附属市中医医院，上海 200071
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20211593
  CLC： R22;R242;R2-031;R256.35
- Received：21 March 2021，
  
  Published Online：03 June 2021，
  
  Published：05 August 2021
- 稿件说明：
移动端阅览
师哲,周蒙恩,张克慧等.加味芪榔方治疗药物依赖性气阴两虚型便秘患者的疗效及对外周血MTL，VIP，5-HT和5-HT4R的影响[J].中国实验方剂学杂志,2021,27(15):51-56.

SHI Zhe,ZHOU Meng-en,ZHANG Ke-hui,et al.Clinical Efficacy of Modified Qilang Prescription in Treatment of Drug-dependent Constipation with Qi and Yin Deficiency and Its Effect on MTL， VIP， 5-HT， and 5-HT4R in Peripheral Blood[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(15):51-56.
师哲,周蒙恩,张克慧等.加味芪榔方治疗药物依赖性气阴两虚型便秘患者的疗效及对外周血MTL，VIP，5-HT和5-HT4R的影响[J].中国实验方剂学杂志,2021,27(15):51-56. DOI： 10.13422/j.cnki.syfjx.20211593.

SHI Zhe,ZHOU Meng-en,ZHANG Ke-hui,et al.Clinical Efficacy of Modified Qilang Prescription in Treatment of Drug-dependent Constipation with Qi and Yin Deficiency and Its Effect on MTL， VIP， 5-HT， and 5-HT4R in Peripheral Blood[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(15):51-56. DOI： 10.13422/j.cnki.syfjx.20211593.

摘要

目的

探究加味芪榔方对药物依赖性气阴两虚型便秘患者的临床疗效及对血清血管活性肠肽（VIP），胃动素（MTL），5-羟色胺（5-HT），5-羟色胺4受体（5-HT4R）的影响。

方法

选取符合药物依赖性气阴两虚型便秘诊断标准的患者160例，随机分为观察组与对照组，每组80例；观察组予加味芪榔方治疗，对照组予乳果糖口服溶液治疗，连续治疗8周。观察2组患者临床疗效，中医证候及血清VIP，MTL，5-HT，5-HT4R水平变化。比较2组临床疗效并进行至少8周复发率、中医证候随访。

结果

观察组患者治疗后总有效率90.91%，对照组75.00%，观察组明显高于对照组（

=-6.514，

0.05）。2组患者治疗前血清VIP，MTL，5-HT，5-HT4R差异无统计学意义。连续用药8周后，2组患者血清VIP水平较治疗前降低（

0.05），且观察组低于对照组（

0.05）；2组患者血清MTL水平均较治疗前升高（

0.05），且观察组明显高于对照组（

0.05）；治疗后观察组5-HT水平明显高于对照组（

0.05）；观察组5-HT4R水平较治疗前略有升高（

0.05），但2组患者治疗后5-HT4R水平差异无统计学意义。随访至少8周，第2，4周观察组复发率明显低于对照组（

0.05），第8周后观察组复发率57.14%（40/70），对照组复发率64.81%（35/54），差异无统计学意义。

结论

加味芪榔方治疗药物依赖性气阴两虚型便秘临床近、中期疗效优于乳果糖，远期疗效不显著，其治疗机制或与调节患者血清VIP，MTL，5-HT水平有关。

Abstract

Objective

To investigate the curative efficacy of modified Qilang prescription on drug-dependent constipation with Qi and Yin deficiency and the effects on serum vasoactive intestinal peptide （VIP）， motilin （MTL）， 5-hydroxytryptamine （5-HT）， and 5-hydroxytryptamine 4 receptor （5-HT4R）.

Method

A total of 160 patients diagnosed with drug-dependent constipation were randomly divided into a treatment group （

=80， Qilang prescription） and a control group （

=80， lactulose oral solution）. The treatment lasted for eight weeks. Changes in clinical symptoms， traditional Chinese medicine （TCM） syndrome， and serum VIP， MTL， 5-HT， and 5-HT4R before and after treatment were observed. The clinical efficacies of the two groups were compared. An eight-week follow-up was carried out for the observation of recurrent rate and TCM syndrome.

Result

The overall response rate of the treatment group （90.91%） was higher than that （75.00%） of the control group

（

=-6.514，

0.05）. There was no significant difference in serum VIP， MTL， 5-HT， and 5-HT4R between the two groups before treatment. After treatment for eight weeks， both groups showed reduced serum VIP level as compared with those before treatment， and the treatment group was inferior to the control group （

0.05）. The serum MTL levels of the two groups were both higher than those before treatment （

0.05）， and the treatment group was superior to the control group （

0.05）. After treatment， the level of 5-HT in the treatment group was higher than that in the control group （

0.05）. The post-treatment 5-HT4R level in the treatment group slightly increased （

0.05）， but no significant difference in 5-HT4R levels between the two groups after treatment was observed. During the eight-week follow-up， the recurrence rate in the treatment group was significantly lower than that in the control group at the 2nd and 4th weeks （

0.05）. There was no significant difference in the recurrence rate between the treatment group ［57.14% （40/70）］ and the control group ［64.81% （35/54）］ after eight weeks.

Conclusion

Modified Qilang prescription was superior to lactulose in the short- and mid-term efficacy on drug-dependent constipation with Qi and Yin deficiency. No significant difference in the long-term efficacy was observed. The underlying therapeutic mechanism might be related to the regulation of serum VIP， MTL， 5-HT， and 5-HT4R levels.

关键词

Keywords

references

中华中医药学会脾胃病分会 . 慢性便秘中医诊疗共识意见［J］. 北京中医药， 2011 ， 30 （ 1 ）： 3 - 7 .

刘访，曹波，李志，等 . 基于“肺与大肠相表里”探析“通腑理肺法”对慢性功能性便秘的治疗进展［J］. 世界中医药， 2020 ， 15 （ 17 ）： 2672 - 2674 .

TAN N ， GWEE K A ， TACK J ， et al . Herbal medicine in the treatment of functional gastrointestinal disorders： a systematic review with Meta-analysis ［J］. J Gastroenterol Hepatol ， 2020 ， 35 （ 4 ）： 544 - 556 .

马继征，刘绍能，吴泰相，等 . 中药治疗慢性功能性便秘效果的系统评价［J］. 中国循证医学杂志， 2010 ， 10 （ 10 ）： 1213 - 1221 .

王健，刘义安，汤健，等 .“ 芪榔合剂”治疗气阴两虚型慢性功能性便秘100例临床研究［J］. 江苏中医药， 2012 ， 44 （ 7 ）： 24 - 25 .

姜入铭，李毅平 . 芪榔合剂治疗气阴两虚型慢性功能性便秘疗效及安全性评价［J］. 长春中医药大学学报， 2013 ， 29 （ 6 ）： 972 - 973 .

李勇，王健，李毅平，等 . 芪榔合剂对慢性传输型便秘小鼠结肠SP、VIP的影响［J］. 世界华人消化杂志， 2008 ， 16 （ 3 ）： 272 - 276 .

王健，汤健，胡晔，等 . 芪榔合剂对功能性便秘小鼠结肠AQP4和AQP8含量的影响研究［J］. 现代中西医结合杂志， 2017 ， 26 （ 29 ）： 3193 - 3195 .

李佳，杨斌，石小乐，等 . 加味济川煎对老年阳虚慢传输型便秘患者MTL、SP、VIP影响的研究［J］. 中国中医药现代远程教育， 2021 ， 19 （ 2 ）： 102 - 105 .

BLACK C J ， FORD A C . Chronic idiopathic constipation in adults： epidemiology，pathophysiology，diagnosis and clinical management ［J］. Med J Aust ， 2018 ， 209 （ 2 ）： 86 - 91 .

贡钰霞，王浩，侯毅，等 . 大剂量生白术配伍枳实对慢传输型便秘大鼠结肠5-HT3R、5-HT4R表达的影响［J］. 中国中西医结合杂志， 2019 ， 39 （ 8 ）： 988 - 992 .

DROSSMAN D A . Functional gastrointestinal disorders： history，pathophysiology，clinical features and Rome Ⅳ ［J］. Gastroenterology ， 2016 ， doi： 10.1053/j.gastro.2016.02.032 http://dx.doi.org/10.1053/j.gastro.2016.02.032 .

中华中医药学会脾胃病分会 . 便秘中医诊疗专家共识意见（2017）［J］. 中医杂志， 2017 ， 58 （ 15 ）： 1345 - 1350 .

黄业保，肖倩，刘春强 . 中医药治疗慢传输型便秘的临床研究进展［J］. 中医药临床杂志， 2020 ， 32 （ 8 ）： 1579 - 1582 .

吕恒刚，宋云平，郭莘 . 便秘的危害及预防［J］. 解放军预防医学杂志， 2019 ， 37 （ 8 ）： 198 .

朱波，杨艳，苏仁意，等 . 右归丸治疗功能性便秘大鼠胃肠动力学和神经递质、水通道蛋白3的影响［J］. 世界中医药， 2019 ， 14 （ 7 ）： 1677 - 1680，1685 .

李毅平，李勇，王健，等 . 芪榔合剂对慢传输型便秘小鼠结肠Cajal间质细胞的影响［J］. 伤害中医药杂志， 2012 ， 46 （ 1 ）： 68 - 71 .

IWASAKI M ， AKIBA Y ， KAUNITZ J D . Recent advances in vasoactive intestinal peptide physiology and pathophysiology： focus on the gastrointestinal system ［J］. F1000Res ， 2019 ， doi： 10.12688/f1000research.18039.1 http://dx.doi.org/10.12688/f1000research.18039.1 .

孙祥珍，马臻棋，马雪芹 . 初探VIP、P物质与便秘的关系［J］. 世界最新医学信息文摘， 2019 ， 19 （ 26 ）： 113 - 114 .

ADACHI H ， TODA N ， HAYASHI S ， et al . Mechanism of the excitatory action of motilin on isolated rabbit intestine ［J］. Gastroenterology ， 1981 ， 80 （ 4 ）： 783 - 788 .

ULUSOY E ， ARSLAN N ， KUME T ， et al . Serum motilin levels and motilin gene polymorphisms in children with functional constipation ［J］. Minerva Pediatr ， 2016 ，PMID：27706119.

CHOO I H ， CHUNG J Y ， CHONG A ， et al . Correlation between depressive symptom and executive function decline in amyloid positive mild cognitive impairment ［J］. Alzheimers Dement ， 2020 ， doi： 10.1002/alz.037745 http://dx.doi.org/10.1002/alz.037745 .

许洁，郁金芬 . 内关穴位按压配合生姜敷贴法对妊娠剧吐患者胃动素水平的影响［J］. 世界中医药， 2020 ， 15 （ 2 ）： 280 - 285 .

杨晨玉，韩亚楠，王子旭，等 . 5-HT转运体/受体在肠道疾病发生中的作用研究进展［J］. 神经解剖学杂志， 2014 ， 30 （ 6 ）： 720 - 724 .

LIU S ， ZHANG L ， YUAN C . Clinical efficacy of Shugan Jieyu capsules in post-stroke depression and its effects on NE and 5-HT levels ［J］. W Chin Med ， 2019 ， 14 （ 7 ）： 1784 - 1788 .

窦迎春，于新娟，许倩倩，等 . 慢性便秘患者血清中5-羟色胺、生长抑素的表达及意义［J］. 中华结直肠疾病电子杂志， 2018 ， 7 （ 1 ）： 42 - 46 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Modified Qilang Prescription on Drug-dependent Constipation of Qi-Yin Deficiency Type

Shugan Jianpi Yangxin Prescription Regulates Orexin-A and Its Receptors in Mouse Model of Insomnia

Mechanism of Shaoyaotang in Treatment of Ulcerative Colitis Based on Network Pharmacology and Experimental Verification

Clinical Effect of Modified Jichuanjian on Senile Patients with Slow Transit Constipation of Spleen-kidney Yang Deficiency Syndrome and Effect on Brain-gut Peptide

Therapeutic Efficacies of Wujiwan at Different Compatibilities in Treatment of Irritable Bowel Syndrome

Related Author

CAO Mengxing

ZHOU Mengen

LI Yong

ZHAO Min

WANG Zhen

ZHANG Jie

LIU Feixiang

SUN Jiangyan

Related Institution

Shanghai Municipal Hospital of Traditional Chinese Medicine （TCM） Affiliated to Shanghai University of TCM

First Clinical Medical College， Henan University of Chinese Medicine

Encephalopathy Hospital， The First Affiliated Hospital of Henan University of Chinese Medicine

School of Life Sciences，Beijing University of Chinese Medicine

Dongzhimen Hospital， Beijing University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰